West Pharmaceutical (WST +9.8%) shares break out to an eight-month high after the company issues upside guidance for Q1. WST sees EPS of $0.83, excluding non-recurring items, vs. $0.65 consensus, on revenues of $316M vs. $308M consensus. FY 2012 EPS estimate is raised to $2.50-$2.67 vs. $2.47 consensus.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Nasdaq.com (Jan 15, 2015)
at Nasdaq.com (Jan 14, 2015)
at Nasdaq.com (Dec 30, 2014)
at Nasdaq.com (Dec 22, 2014)
at CNBC.com (May 5, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs